Skip to content

OPTIMER PHARMACEUTICALS INC

CIK 0001142576

← back to feed
Revenue (TTM)
$107.14M
+9.2% YoY Q2 Aug 2013
Net Income (TTM)
—
Q2 Aug 2013
EPS Diluted (TTM)
−$1.33
+103.6% YoY Q2 Aug 2013
Gross Margin
94.1%
Q2 Aug 2013
Operating Margin
-78.9%
Q2 Aug 2013
Net Margin
—
Q2 Aug 2013
Free Cash Flow (TTM)
—
Q2 Aug 2013
Cash
$72.84M
Q2 Aug 2013
Total Debt
—
Q2 Aug 2013
Shares Outstanding
48.9M sh
Q2 Aug 2013

Revenue & Net Income

EPS (Diluted)

Margins

Revenue Growth (YoY)

Balance Sheet

Cash vs Debt

Recent filings